Stock Markets March 3, 2026

Morgan Advanced Materials Falls Short of 2025 Targets; Thermal Products Division Put Under Review

Company misses EBITA and EPS forecasts, flags Thermal Products as a potential disposal to be resolved in H1 2026

By Jordan Park
Morgan Advanced Materials Falls Short of 2025 Targets; Thermal Products Division Put Under Review

Morgan Advanced Materials reported 2025 results that missed analyst expectations on profitability, driven by weakness in its Thermal Products division and elevated central costs. The company posted modestly higher revenues versus consensus but saw organic revenue decline and margins compress. Management has placed the Thermal Products business under formal review, with a potential outcome expected in the first half of 2026, while providing a 2026 outlook broadly in line with market estimates.

Key Points

  • Morgan Advanced Materials reported 2025 revenues of £1,030 million, above consensus of £1,015 million, but organic revenue fell 3.3% versus an expected 4.3% decline.
  • Adjusted EBITA was £99.1 million, below the consensus £106 million, with an EBITA margin of 9.6% and EPS of 15.9 pence versus expected 19.1 pence.
  • The Thermal Products division, representing 37% of group revenues, is under formal review with a potential disposal and an outcome possible in the first half of 2026; 2026 guidance anticipates 1% to 2% organic growth and an adjusted operating margin of about 10%.

Morgan Advanced Materials said on Tuesday that its full-year 2025 financial results fell short of analyst expectations, with adjusted earnings before interest, tax and amortization coming in 7% below consensus. While reported sales exceeded the market forecast, margin performance and per-share earnings disappointed.

The company recorded 2025 revenues of £1,030 million for the year, versus a consensus projection of £1,015 million. On an organic basis, revenue contracted by 3.3%, which was a smaller decline than the consensus forecast of a 4.3% drop.

Adjusted EBITA was reported at £99.1 million, missing the consensus figure of £106 million, with an EBITA margin of 9.6% compared with the expected 10.4%. Reported earnings per share were 15.9 pence, below the consensus expectation of 19.1 pence.

Net debt at the year end stood at £232 million, up from £226 million at the end of 2024, producing a net debt to EBITDA ratio of 1.8 times.

Management identified its Thermal Products segment and higher central costs as the primary contributors to the shortfall versus forecasts. The company said Thermal Products experienced a soft industrial backdrop during the year, while central cost pressures reflected expenses tied to enterprise resource planning implementation.

By end market, demand for aerospace and defense remained robust, according to the company, while healthcare demand weakened as customers destocked. Exposure to semiconductors and industrial end markets stayed subdued as anticipated, although the company noted stabilization in the second half of 2025. Separately, Performance Carbon benefited from a one-off £5 million of non-repeating trading receipts during 2025.

In a significant strategic move, Morgan Advanced Materials announced a formal review of its Thermal Products division, which represents 37% of group revenues. The review may include a potential disposal, and the company said an outcome from this process could be possible in the first half of 2026.

Looking to 2026, management provided guidance calling for organic revenue growth of 1% to 2% and an adjusted operating margin of around 10%. The company noted that consensus forecasts currently sit at roughly £1,010 million of revenues with EBITA at £100 million.


Clear summary

Morgan Advanced Materials beat headline revenue consensus but missed on EBITA and EPS in 2025. Weakness in Thermal Products and higher central costs were cited as the main drivers of the earnings shortfall. The Thermal Products unit, which accounts for over a third of sales, is under formal review with a potential disposal outcome possible in H1 2026. Management expects modest organic growth and an operating margin near 10% in 2026, broadly consistent with market expectations.

Risks

  • Thermal Products softness poses strategic and financial risk if the review leads to a disposal or prolonged uncertainty, impacting industrial exposure and overall revenues.
  • Elevated central costs related to ERP implementation may continue to pressure margins if project expenses persist or additional costs are incurred.
  • Customer destocking in the healthcare end market and ongoing weakness in semiconductor and industrial demand could suppress near-term revenue growth and earnings until stabilization is sustained.

More from Stock Markets

Markets Retreat as Middle East Conflict Stokes Energy Price Gains; JPMorgan Flags Sector Winners and Losers Mar 3, 2026 Conflict Escalates Across Middle East as Israel Strikes Tehran and Beirut; Iran Mounts Retaliation Mar 3, 2026 Morgan Stanley: Geopolitical Tensions Keep European Stocks Tilted Toward Defensives Mar 3, 2026 On Holding Sees Potential Lift from Lower U.S. Tariff Rate as Results Outperform Mar 3, 2026 UBS Lifts Melia Hotels to Neutral, Raises Price Target on Margin Ambitions Mar 3, 2026